Dr. Janet Woodcock is the director of CDER, FDA and oversees 4000 people and 10000 drugs. At ISPE 2013, Dr. Woodcock began with the statement –“Industry QbD adoption was successful. but QbD submissions were a mixed success. Culture of quality is not there yet.” She also openly talked about...